These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36253862)

  • 21. Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score.
    Schmidt M; Burrell A; Roberts L; Bailey M; Sheldrake J; Rycus PT; Hodgson C; Scheinkestel C; Cooper DJ; Thiagarajan RR; Brodie D; Pellegrino V; Pilcher D
    Eur Heart J; 2015 Sep; 36(33):2246-56. PubMed ID: 26033984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxygen Thresholds and Mortality During Extracorporeal Life Support in Adult Patients.
    Munshi L; Kiss A; Cypel M; Keshavjee S; Ferguson ND; Fan E
    Crit Care Med; 2017 Dec; 45(12):1997-2005. PubMed ID: 28787294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Venoarterial Extracorporeal Membrane Oxygenation for Postcardiotomy Shock-Analysis of the Extracorporeal Life Support Organization Registry.
    Kowalewski M; Zieliński K; Brodie D; MacLaren G; Whitman G; Raffa GM; Boeken U; Shekar K; Chen YS; Bermudez C; D'Alessandro D; Hou X; Haft J; Belohlavek J; Dziembowska I; Suwalski P; Alexander P; Barbaro RP; Gaudino M; Di Mauro M; Maessen J; Lorusso R
    Crit Care Med; 2021 Jul; 49(7):1107-1117. PubMed ID: 33729722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk prediction of in-hospital mortality in patients with venoarterial extracorporeal membrane oxygenation for cardiopulmonary support: The ECMO-ACCEPTS score.
    Becher PM; Twerenbold R; Schrage B; Schmack B; Sinning CR; Fluschnik N; Schwarzl M; Waldeyer C; Seiffert M; Clemmensen P; Neumann JT; Bernhardt AM; Zeymer U; Thiele H; Reichenspurner H; Blankenberg S; Westermann D
    J Crit Care; 2020 Apr; 56():100-105. PubMed ID: 31896442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting mortality in patients undergoing VA-ECMO after coronary artery bypass grafting: the REMEMBER score.
    Wang L; Yang F; Wang X; Xie H; Fan E; Ogino M; Brodie D; Wang H; Hou X
    Crit Care; 2019 Jan; 23(1):11. PubMed ID: 30635022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percutaneous Venoarterial Extracorporeal Membrane Oxygenation for Refractory Cardiogenic Shock Is Associated with Improved Short- and Long-Term Survival.
    Hryniewicz K; Sandoval Y; Samara M; Bennett M; Cabuay B; Chavez IJ; Seatter S; Eckman P; Zimbwa P; Dunn A; Sun B
    ASAIO J; 2016; 62(4):397-402. PubMed ID: 27045967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracorporeal membrane oxygenation for refractory cardiogenic shock: patient survival and health-related quality of life.
    Jäämaa-Holmberg S; Salmela B; Suojaranta R; Jokinen JJ; Lemström KB; Lommi J
    Eur J Cardiothorac Surg; 2019 Apr; 55(4):780-787. PubMed ID: 30534984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term survival of adults with cardiogenic shock after venoarterial extracorporeal membrane oxygenation.
    Burrell AJ; Pellegrino VA; Wolfe R; Wong WK; Cooper DJ; Kaye DM; Pilcher DV
    J Crit Care; 2015 Oct; 30(5):949-56. PubMed ID: 26111916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperoxia during venoarterial ECMO: Culprit or co-variate? A comment from the BLENDER investigators.
    Premraj L; Brown A; Burrell A; Fraser JF; Pilcher D
    Crit Care; 2022 Nov; 26(1):345. PubMed ID: 36348428
    [No Abstract]   [Full Text] [Related]  

  • 30. VA-ECMO Support in Nonsurgical Patients With Refractory Cardiogenic Shock: Pre-Implant Outcome Predictors.
    Fux T; Holm M; Corbascio M; Lund LH; van der Linden J
    Artif Organs; 2019 Feb; 43(2):132-141. PubMed ID: 30402887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Venoarterial extracorporeal membrane oxygenation for cardiogenic shock and cardiac arrest: a meta-analysis.
    Xie A; Phan K; Tsai YC; Yan TD; Forrest P
    J Cardiothorac Vasc Anesth; 2015; 29(3):637-45. PubMed ID: 25543217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival following venoarterial extracorporeal membrane oxygenation in postcardiotomy cardiogenic shock adults.
    Chen F; Wang L; Shao J; Wang H; Hou X; Jia M
    Perfusion; 2020 Nov; 35(8):747-755. PubMed ID: 32529901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporary circulatory support with extra corporeal membrane oxygenation in adults with refractory cardiogenic shock.
    Liden H; Wiklund L; Haraldsson A; Berglin E; Hultman J; Dellgren G
    Scand Cardiovasc J; 2009 Aug; 43(4):226-32. PubMed ID: 19089752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ECMO use and mortality in adult patients with cardiogenic shock: a retrospective observational study in U.S. hospitals.
    El Sibai R; Bachir R; El Sayed M
    BMC Emerg Med; 2018 Jul; 18(1):20. PubMed ID: 29973150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unloading of the Left Ventricle During Venoarterial Extracorporeal Membrane Oxygenation Therapy in Cardiogenic Shock.
    Schrage B; Burkhoff D; Rübsamen N; Becher PM; Schwarzl M; Bernhardt A; Grahn H; Lubos E; Söffker G; Clemmensen P; Reichenspurner H; Blankenberg S; Westermann D
    JACC Heart Fail; 2018 Dec; 6(12):1035-1043. PubMed ID: 30497643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Venoarterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock and Cardiac Arrest.
    Rao P; Khalpey Z; Smith R; Burkhoff D; Kociol RD
    Circ Heart Fail; 2018 Sep; 11(9):e004905. PubMed ID: 30354364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical utility of venoarterial-extracorporeal membrane oxygenation (VA-ECMO) in patients with drug-induced cardiogenic shock: a retrospective study of the Extracorporeal Life Support Organizations' ECMO case registry.
    Weiner L; Mazzeffi MA; Hines EQ; Gordon D; Herr DL; Kim HK
    Clin Toxicol (Phila); 2020 Jul; 58(7):705-710. PubMed ID: 31617764
    [No Abstract]   [Full Text] [Related]  

  • 38. Venoarterial extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock-A six-year service evaluation.
    Charlesworth M; Garcia M; Head L; Barker JM; Ashworth AD; Barnard JB; Feddy L; Venkateswaran RV
    Artif Organs; 2020 Jul; 44(7):709-716. PubMed ID: 31970800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood Lactate as a Reliable Marker for Mortality of Pediatric Refractory Cardiogenic Shock Requiring Extracorporeal Membrane Oxygenation.
    Yang L; Fan Y; Lin R; He W
    Pediatr Cardiol; 2019 Mar; 40(3):602-609. PubMed ID: 30600369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Awake venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock.
    Montero S; Huang F; Rivas-Lasarte M; Chommeloux J; Demondion P; Bréchot N; Hékimian G; Franchineau G; Persichini R; Luyt CÉ; Garcia-Garcia C; Bayes-Genis A; Lebreton G; Cinca J; Leprince P; Combes A; Alvarez-Garcia J; Schmidt M
    Eur Heart J Acute Cardiovasc Care; 2021 Aug; 10(6):585-594. PubMed ID: 33822901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.